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Engaging patients and parents to improve
mental health intervention for youth with
rheumatological disease
Oluwatunmise A. Fawole1,2,3, Michelle V. Reed1, Julia G. Harris4, Aimee Hersh5, Martha Rodriguez6, Karen Onel7,
Erica Lawson8, Tamar Rubinstein9, Kaveh Ardalan10,11,12, Esi Morgan13, Anne Paul13, Judy Barlin14, R. Paola Daly14,
Mitali Dave15, Shannon Malloy15, Shari Hume15, Suzanne Schrandt16, Laura Marrow16, Angela Chapson1,
Donna Napoli1, Michael Napoli1, Miranda Moyer1, Vincent Delgaizo17,18, Ashley Danguecan19, Emily von Scheven8,
Andrea Knight1,2,19,20* and for the CARRA Investigators

Abstract
Background: Mental health disorders are common in youth with rheumatological disease yet optimal intervention
strategies are understudied in this population. We examined patient and parent perspectives on mental health
intervention for youth with rheumatological disease.
Methods: We conducted a mixed methods cross-sectional study, via anonymous online survey, developed by
researchers together with patient/parent partners, to quantitatively and qualitatively examine youth experiences
with mental health services and resources in North America. Patients ages 14–24 years with juvenile idiopathic
arthritis, juvenile dermatomyositis, or systemic lupus erythematous, and parents of patients ages 8–24 with these
diseases were eligible (not required to participate in pairs). Participants self-reported mental health problems
(categorized into clinician-diagnosed disorders vs self-diagnosed symptoms) and treatments (e.g. therapy,
medications) received for the youth. Multivariate linear regression models compared patient and parent mean Likert
ratings for level of: i) comfort with mental health providers, and ii) barriers to seeking mental health services,
adjusting for potential confounders (patient age, gender, disease duration, and patient/parent visual analog score
for disease-related health). Participants indicated usefulness of mental health resources; text responses describing
these experiences were analyzed by qualitative description.
(Continued on next page)
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Results: Participants included 123 patients and 324 parents. Patients reported clinician-diagnosed anxiety (39%) and
depression (35%); another 27 and 18% endorsed self-diagnosed symptoms of these disorders, respectively. 80% of
patients with clinician-diagnosed disorders reported receiving treatment, while 11% of those with self-diagnosed
symptoms reported any treatment. Patients were less comfortable than parents with all mental health providers.
The top two barriers to treatment for patients and parents were concerns about mental health providers not
understanding the rheumatological disease, and inadequate insurance coverage. Over 60% had used patient mental
health resources, and over 60% of these participants found them to be helpful, although text responses identified a
desire for resources tailored to patients with rheumatological disease.
Conclusion: Self-reported mental health problems are prevalent for youth in this sample with rheumatological
disease, and obstacles to mental health treatment include disease-related and logistic factors. Strategies are needed
to improve acceptance and accessibility of mental health intervention, including routine mental health screening
and availability of disease-specific mental health resources.
Keywords: Children, Mental health, Patient-engaged approach, Rheumatology, Mental health interventions, Survey

Background
Patients with rheumatological diseases such as juvenile
idiopathic arthritis (JIA), juvenile dermatomyositis
(JDM), or childhood-onset systemic lupus erythematous
(cSLE) may experience high psychological burden associated with their disease. Reported prevalence rates of depression and anxiety range from 15 to 65% [1]. Mental
health disorders are associated with adverse outcomes in
these patients, including decreased quality of life, suboptimal medication adherence, increased disease activity
and pain, and challenges with transition to adult care
[2–7]. Despite studies showing efficacy of mental health
interventions in pediatric rheumatology patients [8–10],
it has been recognized that mental health problems are
often underdiagnosed and untreated. According to a
2015 survey of pediatric rheumatologists in the Childhood Arthritis & Rheumatology Research Alliance
(CARRA), a collaborative research alliance which includes 90% of pediatric rheumatologists in North America, 52% of respondents reported inadequate mental
health symptom identification and 45% reported inadequate treatment of depression and anxiety amongst
their patients with cSLE [11]. These findings were
echoed by a mixed methods study of behavioral health
providers, who identified several gaps in mental health
care for pediatric rheumatology patients, including lack
of protocols for screening, intervention, and follow-up, a
need for integration of mental health providers into
medical care, and better access to peer support resources
for patients and families [12].
Understanding patient and parent perspectives on
mental health care is essential to assessing patients’
health status and service gaps [13–16]. To our knowledge, there has only been one qualitative single center
study looking at patient and parent perspectives on barriers and facilitators to addressing mental health needs

in youth with rheumatological disease; it found that
pediatric rheumatologists were perceived as a preferred
source for mental health care referral and resources [17].
Additionally, there is emerging recognition of the importance of patient and parent engagement in pediatric
chronic disease research in order to maximize the relevance, quality, and acceptability of study findings [18,
19]. Involving patients and families as members of the
research team in the design, implementation and interpretation of studies (i.e. using a patient-engaged approach) is a valuable strategy for exploring sensitive
topics such as mental health.
The objective of this study was to investigate patient
and parent perspectives on mental health intervention
for youth with rheumatological disease, using a patientengaged approach. Specifically, we conducted a mixed
methods study to: i) characterize experiences and perceptions about mental health services and resources for
patients with JIA, JDM or cSLE, ii) identify perceived
barriers to utilization of these services, and iii) compare
patient and parent perspectives for these responses.

Methods
Study design We conducted an anonymous, online
cross-sectional survey of patients with rheumatological
disease, and parents. A patient-engaged approach was
used from development through conduction of the
study, leveraging the Patients, Advocates, and Rheumatology Teams Network for Research and Service (PART
NERS), a patient-powered research network funded by
the Patient-Centered Outcomes Research Institute
(PCORI), which includes the CARRA network, the
Pediatric Rheumatology Care and Outcomes and Improvement Network (PR-COIN), and 3 patient organizations (Arthritis Foundation, Lupus Foundation of

Fawole et al. Pediatric Rheumatology

(2021) 19:19

America, and Cure JM Foundation). The PARTNERS
network formally links pediatric rheumatologists, researchers, and JIA, JDM, and cSLE patients and family
members, who are central collaborators in the research.
The survey was drafted by the CARRA SLE Mental
Health Workgroup in collaboration with three patient
and three parent advisors, who contributed critical feedback surrounding inclusion of response item options to
capture the range of mental health experiences, in
addition to content guided by the literature [7, 11, 17,
20]. The survey was then iteratively refined to incorporate input from these advisors, and representatives from
the other organizations in PARTNERS. The study was
approved by the Institutional Review Boards for the
Children’s Hospital of Philadelphia (CHOP), Duke University, the Lupus Foundation of America, and the Hospital for Sick Children.

Participants & setting

Eligible patients were ages 14–24 years reporting a diagnosis of JIA, JDM or cSLE, and receipt of specific treatment [including: non-steroidal anti-inflammatory drugs
(NSAIDs); glucocorticoids (oral, intravenous, or intraarticular); conventional disease modifying anti-rheumatic
drugs (DMARDs); and biologic DMARDs]. Parents of
patients ages 8–24 years were also eligible to participate;
to facilitate anonymity, they were not required to participate in pairs with their children. Age inclusion criteria
were generally aligned with the definition of youth according to the US Department of Health and Human
Services Healthy People 2020 Objectives (which includes
adolescents ages 10–17 and young adults ages 18–25)
[21]. However, we utilized the following modifications:
lower age of 14 years for patients to enable consent for
their own participation, and facilitate anonymous response; eligibility of parents of patients ages 8 and older,
based on parent advisor feedback regarding the importance of characterizing mental health for pre-adolescent
patients.
The survey was conducted anonymously to maximally
elicit personal information about mental health, while
reducing underreporting or misreporting which can
occur due to social desirability bias around sensitive
topics [22]. To recruit participants living in the United
States and Canada, we leveraged the patient organizations in the PARTNERS network (Arthritis Foundation,
Lupus Foundation of America, and Cure JM Foundation). Participants accessed the REDCap survey via
weblink between August 2017 to August 2018, sent via
email listservs, and available on websites and social
media sites for the above 3 patient organizations; the
weblink was also available via local advertisements at
nine participating CARRA clinics. Data was managed
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using the secure, REDCap web application designed to
support data capture for research [23].
Survey instrument

The anonymous online survey, available in English and
Spanish (using forward and back-translation methods),
comprised quantitative and qualitative items to examine
experiences with mental health care for patients with
JIA, JDM or cSLE. The survey captured the following patient disease characteristics: rheumatological diagnosis,
medications, disease duration and activity (active vs inactive), visual analog score (VAS) for disease-related
health (0 = very well and 10 = very poor). Active disease
was defined across disease groups by an affirmative response to both of the following the questions: “Is your
disease currently active (not under good control, with or
without medication)?”, and “Has your rheumatologist
told you that your disease is currently active/ not active?”. Patient demographics included age, gender, race,
ethnicity, household income and education level, insurance, and location [United States census region used by
the Centers for Disease Control and Prevention [24], or
Canada (regions not included due to small Canadian
sample]. Participants also provided mental health history
including: clinician-diagnosed mental health disorders
(by a rheumatologist, psychiatrist, pediatrician/family
care doctor, other doctor, or psychologist), past or
current self-diagnosed mental health symptoms, and
past or current mental health treatment received (e.g.
therapy or counseling, psychotropic medications, or inpatient psychiatric care). Additionally, in response to a
hypothetical vignette simulating a situation of emotional
distress for the patients (Additional File 1), participants
used a Likert scale to rate their: i) level of comfort with
potential mental health providers (0 = very uncomfortable, 4 = very comfortable), and ii) level of concern about
potential barriers (16 for patients, 17 for parents) to
seeking help from a mental health professional (0 = not
at all, 4 = extremely), based on known correlates of unmet need for mental health services in children and adolescents [20, 25]. We also collected information on the
broad scope of types of mental health resources that participants had used (including general counseling services,
peer support groups, camps, online resources, and
printed handouts/resources). We asked participants who
had used these resources if they found them to be helpful, not helpful, or if they were unsure if the resource
was helpful. These participants were then asked to provide a qualitative text entry explaining their response.
Statistical analysis

Participant characteristics were summarized using frequencies and proportions for categorical variables, and
means and standard deviations or medians and
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interquartile ranges for continuous variables, as appropriate. Ineligible responders and incomplete responses
(from unsubmitted surveys) were excluded. We measured the prevalence of self-reported mental health
problems for patients with rheumatological disease,
stratifying responses by mutually exclusive groups for
clinician-diagnosed disorders versus self-diagnosed
symptoms, and tabulated reported mental health treatments received by these groups. For participants indicating use and helpfulness of mental resources, qualitative
text responses were analyzed using qualitative description to summarize positive or negative experiences with
mental health resources, and illustrative text responses
were selected. Qualitative description is a low-inference
approach that presents the facts from exactly the informants’ point of view. It is the qualitative method of
choice when only a description of a phenomenon is desired, and is particularly useful in health care research to
focus on the patient experience, for the purpose of needs
assessment and intervention development [26–28].
We calculated mean Likert scores for level of comfort
with potential mental health providers, and frequency of
barriers to seeking mental health treatment. Using
multivariate linear regression to control for potential
confounders (patient age, gender, disease duration, and
patient/parent VAS), we used two separate models to
compare patient and parent responses for ratings for
comfort level with mental health providers, and frequency of barriers to mental health treatment. We also
conducted two stratified regression analyses to compare
responses by:1) patient age group (14–17 versus 18–24
years) to determine if the results differed between adolescents and young adults; and 2) presence or absence of
reported mental health problem (either clinician- or selfdiagnosed), to determine if actual experience with a
mental problem impacted the results. Analysis was conducted using Stata(R) Data Analysis and Statistical Software version 15.0. Alpha ≤0.05 denoted a statistically
significant result.

Results
The survey was initiated by 749 respondents. The following respondents were excluded in a sequential fashion: 53 who did not indicate consent; 63 who did not
indicate an eligible rheumatological diagnosis; 44 who
did not indicate specific treatment; 10 indicating age
above the eligible range; 132 with incomplete mental
health survey items. This resulted in a final survey sample of 447.
Subject characteristics

Four hundred forty-seven respondents included 123 patients and 324 parents. Nine respondents (2%) completed the Spanish version of the survey. The most
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prevalent diagnosis was JIA for both patient (41%) and
parent (49%) respondents, followed by JDM (35 and
40%), and cSLE (24 and 11%). The most common treatments received for rheumatological disease were conventional disease-modifying anti-rheumatic drugs (DMAR
Ds) by > 90% of patients. For JIA participants, ever use
of methotrexate (80%) and oral glucocorticoids (54%)
approximated that for large CARRA JIA Registry cohort
(73 and 47%) [29]. Additional disease and demographic
characteristics are shown in Table 1.

Prevalence of reported mental health problems and
treatments received

A history of any clinician-diagnosed or self-diagnosed
mental health problem among patients was reported by
92 patients (75%) and 201 parents (62%). Patients most
commonly reported problems with anxiety (66%), depression (53%), and adjustment (37%) (Fig. 1), which
paralleled those reported by parents (Table 2). History of
suicidal thoughts (23%), attention deficit disorders
(20%), and eating disorders (18%) were also frequently
reported by patients. Adjusted models controlling for patient age, gender, disease duration, and patient/parent
VAS showed no significant difference between patients
and parents for reported mental health problems.
Of the 92 patients reporting a history of at least one
mental health problem, 32 (35%) indicated a cliniciandiagnosed disorder only, 37 (40%) indicated self-diagnosed
symptoms only, and 17 (18%) indicated both a cliniciandiagnosed disorder and self-diagnosed symptoms (6 did
not specify). For every type of mental health problem,
more than a third of patients reporting the problem had
self-diagnosed symptoms rather than a clinician diagnosis,
with the exception of post-traumatic stress disorder and
attention deficit disorder (Fig. 1). For patients with mental
health problems, 46% of patients indicated that their
rheumatologist was aware of the problem, compared to
70% of parents (p < 0.0001, Z = -3.87, test of proportions).
Of patients with a reported mental health problem (including clinician and self-diagnosed), receipt of mental
health treatment was reported by 44 of 92 (48%) patients
and 128 of 201 (65%) parents (Table 2). Psychotherapy or
counseling was the most common reported treatment modality, reported by 41% of patients and 57% of parents.
About a third of patients reported receiving psychotropic
medications, and < 10% of reported receiving inpatient
psychiatric care. Of those reporting a clinician-diagnosed
disorder, 39 of 49 (80%) patients reported receiving mental health treatment; parents indicated that 90 of 115
(78%) patients had received treatment. Of the 37 patients
reporting self-diagnosed symptoms only, 4 (11%) reported
receiving mental health treatment; parent report indicated
that 27 of 62 (44%) received treatment.
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Table 1 Characteristics of patients with rheumatologic disease reported by patients and parents
Patient Characteristic

Patient Report, N = 123

Patient Report, N = 324

Rheumatologic diagnosis
Juvenile idiopathic arthritis (JIA)

50 (41)

160 (49)

Juvenile dermatomyositis (JDM)

43 (35)

130 (40)

Systemic lupus erythematosus (cSLE)

30 (24)

34 (11)

114 (93)

293 (90)

Immunosuppressive medications ever takena
Conventional disease-modifying anti-rheumatic drugs (DMARDS)
Biologic DMARDS

65 (53)

143 (44)

Glucocorticoids (oral, intravenous or intra-articular)

113 (92)

256 (79)

Active disease status (Y/N)

68 (55)

167 (52)

Visual analog score of disease-related health

3.6 (1.8, 6.2)

2.9 (1.3, 5.1)

Disease duration, years

8 (5, 12)

5 (2, 8)

Age, years

19 (16, 23)

13 (10, 17)

8 to 11

0 (0)

112 (35)

12 to 17

46 (37)

145 (45)

18 to 24

77 (63)

67 (21)

115 (94)

235 (73)

Asian

8 (7)

10 (3)

Black or African American

3 (2)

15 (5)

White

96 (78)

264 (81)

Other

16 (13)

35 (11)

Age group

Female
Race

Hispanic/Latino ethnicity

15 (13)

37 (12)

Household income above federal poverty line

99 (80)

288 (89)

Highest household education level
Below College

35 (28)

62 (19)

College Degree

56 (46)

136 (42)

Advanced Degree

30 (24)

126 (39)

Public

19 (15)

49 (15)

Private

76 (62)

252 (78)

Other

8 (7)

17 (5)

None

1 (< 1)

6 (2)

Northeast US

34 (28)

56 (18)

Midwest US

22 (18)

77 (25)

West US

34 (28)

94 (27)

South US

25 (20)

65 (21)

Canada

1 (< 1)

7 (2)

Primary insurance for patient

Location

Categorical variables are shown as number (percentage);continuous variables reported with median (interquartile range). There were significant
differences in patient and parent responses for patient age (p < 0.0001), disease duration (p < 0.0001), and VAS (p = 0.01) by Wilcoxon rank-sum test,
and for gender (p < 0.001) by Pearson χ2. The following variables had missing data: active disease status (n = 35), ethnicity (n = 9), poverty (n = 2), region
(n = 32). Gender was reported to be “male” by n = 96 and “other” by n = 1
a
Conventional DMARDs reported include: methotrexate (66% of patients and 79% of parents), hydroxychloroquine (58 and 39%) intravenous
immunoglobulin (24 and 32%), mycophenolate (28 and 25%), less commonly azathioprine, cyclosporine, tacrolimus, cyclophosphamide, sulfasalazine
and leflunomide, dapsone and colchicine. Biologic DMARDS include: etanercept (28 and 26%), adalimumab (18 and 18%), rituximab (19 and 9%),
abatacept (8 and 8%), less commonly infliximab, tocilizumab, canakinumab, ustekinumab, anakinra, tofacitinib, certolizumab, golimumab, belimumab,
secukinumab, and rilonacept. Glucocorticoid treatment reported includes oral/intravenous medication (89 and 74%) and joint injections (25 and 21%)
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Fig. 1 Results are shown for the prevalence of mental health problems reported by patients with rheumatological disease, categorized by
clinician-diagnosed disorders and self-diagnosed symptoms. The category for other mental health problem includes bipolar disorder/psychosis,
oppositional defiant disorder and substance abuse

Attitudes & barriers for seeking mental health services

In response to the hypothetical vignette simulating a
situation of emotional distress for youth with rheumatological disease, patients were significantly less comfortable seeking help from all potential mental health
providers than parents, adjusting for patient age, gender,
disease duration, and patient/parent VAS (Fig. 2). While
both groups felt most comfortable with rheumatologists
(mean Likert score for patients 2.85 vs parents 3.54, p <
0.0001) and primary care providers (PCPs) (patients 2.53
vs parents 3.36, p < 0.0001), they were least comfortable
with social workers at the primary care (patients 1.54 vs
parents 2.26, p < 0.0001) and rheumatologist office (patients 1.85 vs parents 2.66, p < 0.0001), and school counselors/therapists (patients 1.69 vs parents 2.47, p <
0.0001). There were no significant differences in level of
comfort with mental health providers when respondents
were stratified by patient age (14–17 vs 18–24). When
stratified by reported mental health problem in the patients, those reporting a problem were significantly more
comfortable interacting with counselors/therapists in the
community than those without (2.72 vs 2.51, p = 0.038),
adjusting for other potential confounders.
In response to items for the hypothetical vignette regarding barriers to accessing mental health services (16
for patients, 17 for parents), patients and parents both
rated the following in the top two barriers: concerns that

mental health professionals would not understand the
rheumatological disease; and that insurance coverage
would be inadequate (Fig. 3). Another barrier rated
among the top five by both patients and parents included patients not wanting to go/feeling uncomfortable
with accessing mental health services. However, there
were also statistically significant differences between patient and parent Likert ratings among the top five barriers, after adjusting for potential confounders.
Specifically, patients reported more concern about not
wanting to take medication for mental health problems
(patient 1.63 vs parent 1.27, p = 0.01), whereas parents
were more concerned that patients would not want
others to find out about mental health treatment (patient 1.14 vs parents 1.38, p = 0.04). There were no significant differences in ratings when stratified by age
group or presence of a mental health problem.

Experiences with mental health resources

69% of patients (n = 85) and 63% of parents (n = 207) reported use of a patient mental health resource (Table 3),
of which online informational resources were most common by patient report, and patient counseling services
by parent report. Fifty-two (61%) patients and 148 (72%)
parents thought the mental health resources were
helpful.
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Table 2 Prevalence of Reported Mental Health Problems and Treatment Received Among Patients with Rheumatologic Disease
Prevalence of Reported Mental Health Problems Among
Patients
Any mental health problem

Patient Report, N = 123

Patient Report, N = 324

N(%)

N(%)

92 (75)

201 (62)

Depression

65 (53)

103 (32)

Anxiety

81 (66)

172 (53)

Adjustment disorder

46 (37)

95 (30)

Suicidal thoughts

28 (23)

40 (12)

Self-injury

15 (12)

18 (6)

Post-traumatic stress disorder

10 (8)

34 (10)

Bipolar disorder/ psychosis

12 (10)

7 (2)

Eating disorder

24 (20)

18 (6)3

Attention deficit disorder

25 (20)

66 (20)

Oppositional defiant disorder

2 (2)

18 (6)

Substance abuse/addiction to alcohol or drugs

5 (4)

4 (1)

Treatment Received by Patients with Mental Health Problems

Patient Report, N = 92

Patient Report, N = 201

Any mental health treatment

44 (48)

128 (65)

Psychotherapy/counseling

38 (41)

112 (57)

25 (66)

87 (78)

Location of services received
Therapist office in community
School

7 (8)

14 (13)

Clinic at rheumatologist hospital/location

6 (16)

30 (27)

Psychiatric hospital/facility

4 (4)

3 (3)

30 (33)

64 (32)

Psychotropic medicationsa
Anti-depressants

23 (77)

41 (64)

Anti-anxiety

11 (37)

17 (27)

Other

2 (7)

19 (30)

I don’t know

4 (13)

2 (3)

Primary care/family doctor

16 (53)

27 (42)

Community mental health provider

12 (40)

24 (38)

Mental health provider at rheumatologist hospital/location

2 (7)

11 (17)

Prescriber for those receiving medicationsa

Other specialist doctor
Inpatient Psychiatric Care

6 (20)

11 (17)

5 (5)

13 (7)

a

The sum of percentages might exceed 100%, as the respondents were allowed to select all that applied

Illustrative quotes for qualitative text responses of experiences with patient mental health resources are
shown in Table 4. Respondents described positive experiences with counselors who helped patients process
emotions and pain, but several indicated negative experiences with counselors who did not understand the impact of the rheumatological disease on mental health.
Other comments shed light on the high cost and scheduling/logistic challenges associated with counseling services. Respondents indicated that disease-specific online
resources were informative, and those with social media
communities were helpful; however, patients sometimes

felt uncomfortable sharing very personal information
through online social platforms, and found it challenging
to be reminded of their struggles with rheumatological
disease. Peer support groups were also identified as opportunities to hear from other patients experiencing
similar problems, although some commented that it was
sometimes difficult to overcome unease about sharing
personal details about their lives. Summer camps were
seen as beneficial because patients could be around
people like them who understood what it was like to
have a rheumatological disease. However, some patients
reported not being able to engage in summer camps if
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Fig. 2 Results are shown for linear regression models comparing Likert ratings for level of comfort with mental health providers between patients
and parents. Models were adjusted for patient age, gender, disease duration, and patient/parent visual assessment score for disease-related
health. *p < 0.01, **p < 0.001, ***p < 0.0001. Beta coefficients were as follows for: psychiatrist (0.44), counselor/therapist in your community (0.65),
school counselor/therapist (0.74), psychologist in your community (0.78), psychologist at rheumatologist office (0.60), social worker at
rheumatologist office (0.85), rheumatologist (0.74), PCP (0.78), social worker at PCP office (0.81)

Fig. 3 Results are shown for the top five barriers to seeking mental health services for patients, rated by patients and parents
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Table 3 Reported Use of Mental Health Resources for Patients with Rheumatological Disease
Patient Report, N = 85

Patient Report, N = 207

N(%)

N(%)

Online information

51 (60)

48 (23)

Counselor/therapist

38 (45)

105 (51)

Mental health brochures/books

27 (32)

56 (27)

Types of Mental Health Resources Used

Peer support groups

27 (32)

43 (21)

Psychologist

27 (32)

65 (31)

School guidance counselor

23 (27)

79 (38)

Camps with patients with a similar rheumatological condition

21 (25)

75 (36)

Psychiatrist

20 (24)

40 (19)

Social worker

19 (22)

36 (17)

Religious youth groups

15 (18)

42 (20)

Telephone-based mental health services

5 (6)

7 (3)

Othera

10 (12)

20 (10)

a

Other includes family, close friends, including family and close friends in the mental health profession, academic conferences for pediatric rheumatological
disease, art therapy, life coaches, and other specialist doctors

their disease was too severe or if the camp did not have
enough focus on their specific rheumatological disease
(Table 4). Print books were also helpful, but noted to be
scarce by some respondents.

Discussion
To our knowledge, this is the largest study focusing on
mental health needs for youth with rheumatological disease from the perspective of patients and parents, yielding several key findings to guide improvement of mental
health intervention. First, our sample reported a high
prevalence of mental health problems affecting the patients, including both clinician-diagnosed disorders and
a notable proportion of self-diagnosed symptoms. While
most patients with a clinician-diagnosed disorder had received mental health services, more than half with selfdiagnosed mental health symptoms had not. Second, patients were less comfortable than parents with all mental
health providers, and there was a greater discomfort
with typical mental health providers (such as counselors/therapists, social workers, psychologists) for both
groups. Additionally, key barriers to seeking mental
health treatment for both patients and parents included
concern about lack of disease understanding by mental
health providers, and lack of adequate insurance coverage due to high cost of mental health services. Finally,
although participants reported use of several helpful
mental health resources, they desired more diseasespecific resources to provide specialized and individualized support. These important insights provide several
targets for improving mental health education and resource utilization, through collaborative relationships between youth with rheumatological disease, their families,

medical and mental health providers. These targets are
also aligned with those of the recent American Board of
Pediatrics Roadmap Project (https://www.abp.org/
foundation/roadmap), which acknowledges the substantial mental health needs of patients and families with
chronic pediatric health conditions, and endeavors to address these needs through development of mental health
tools and resources.
Anxiety and depression were the most prevalent
clinician-diagnosed mental health disorders amongst
survey respondents at 39 and 35%, respectively, which
are also the most prevalent mental health disorders in
the general youth population at 8 and 20% [30, 31]. Our
findings are supported by other studies of youth with
rheumatological disease [4, 5, 7], and parallel reported
depression and anxiety rates for other pediatric chronic
disease populations [32, 33]. We also expand understanding of the mental health burden for youth with
rheumatological disease, as adjustment disorder,
attention-deficit disorder, suicidal thoughts, and eating
disorder were commonly reported. The high rate of reported mental health problems for youth with rheumatological disease underscores the need for routine
mental health screening in this population, particularly
because patients might not feel comfortable reporting
their mental health symptoms to their parents or other
care providers.
While it is encouraging that most (80%) of the patients
with clinician-diagnosed mental health disorders were
reported to have received treatment, the proportion was
much lower for substantial group with self-diagnosed
symptoms only, and most pronounced for patient vs
parent report (11% vs 44%). Providing mental health
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Table 4 Illustrative Quotes for Experiences with Mental Health Resources for Patients with Rheumatologic Disease
Mental
Health
Resources
Used

Helpful

Not Helpful/Unsure

Counseling

“The counselor helped me understand that what I was feeling
was valid, and helped me put a name to the feelings and be able
to process them.”
–Patient, age 23
“The therapist helped him deal with school issues bothering him,
how to handle his moods, how to optimize his time when not
feeling well and helped us as a family have productive and more
meaningful conversations.”
–Parent for patient, age 24
“Our daughter likes having someone else to talk to other then her
mom and dad. The therapist helped her cope with the injection
and IV.”
–Parent for patient, age 9
“Having a therapist to talk to about her pain and how it affects
her has been very helpful.”
–Parent for patient, age 8

“Therapy was extremely expensive and the therapist we saw was
convinced our daughter had a specific genetic mutation never
addressed her anger and mood swings.”
–Parent for patient, age 8
“Counseling was very infrequent due to distance to connect
with a psychologist who was knowledgeable on JDM.”
–Parent for patient, age 9
“Child was not very compliant; Child did not ‘buy in to’ the
therapy - said what he thought the therapist wanted to hear;
didn’t absorb the tools he was learning to cope with anxiety/
social anxiety. Therapist meant well, but didn’t completely ‘get’
JDM.”
–Parent for patient, age 16
“I don’t like talking to strangers about specific things (like
counseling or therapy) so I didn’t feel like it was helpful to me
specifically.”
–Patient, age 21

Peer Support
Groups

“Support group made me think about worse cases related to
Lupus, but also and most importantly my symptoms were
understood.”
–Patient, age 19
“It is nice to hear about other people going through similar and
different situations. It is very lonely sometimes when no one
around you really understands what is going on...it is only made
worse when you don’t understand what is going on a lot of the
times.”
–Patient, age 24

“She attends youth group on a regular basis, thought I am not
certain that she applies any content directly to her JIA
diagnosis.”
– Parent for patient, age 15
“It was called a lunch bunch group in elementary school for a
group (about 5) children. I don’t believe any of the children
opened up to others due to uneasiness/embarrassment. Did not
last long-about 4 sessions.”
–Parent for patient, age 13

Disease“Summer camp is amazing!! We talked about things that other
related Camps people just don’t get.”
–Patient, age 14
“Camp was amazing. Being around ‘people like me’ is one of the
things she loved about it. If she needed to stop an activity and
wrap her ankle no one made a big deal about it.”
–Parent for patient, age 15
“Camps/conferences where families attend have been extremely
helpful.”
–Parent for patient, age 13

“The camp I attended was for kids with JA and JDM, and
because my disease has been so severe, I did not relate or grow
close to them.”
–Patient, age 18
“The camp was for people with all types of rheumatic diseases,
so I was not able to get close to them.”
–Patient, age 18

Online
Resources

“I recently found a group of kids whom also have JDM and have
a private page set up on Facebook. It was really nice when I
found it because it showed me I wasn’t alone and other people
are facing similar issues.”
—Patient, age 14
“The Cure JM website and associated Juvenile Myositis Australia
Inc. have been incredibly supportive and informative.”
–Parent for patient, age 8

“The online support group is nice for talking, but I don’t feel
comfortable saying all that is going on.”
–Patient, age 18
“In the [online] group people support each other and give
advice to one another. However, I do not visit the group page
that often because being reminded that I have JDM and the
struggles of being sick would dampen my mood.”
—Patient, age 14

Print
Handouts/
Resources

“The ‘Myositis and You’ book was incredibly helpful and still is to
this day. A must have for everyone newly diagnosed.”
–Parent for patient, age 8

“Those resources, besides online, are not available in our area/
smaller areas.”
–Parent for patient, age 17

education to youth with rheumatological disease may
help increase perceived usefulness and benefits of mental
health services. Our participants found online and print
resources to be helpful, and educational resources are
known to be a facilitator for youth seeking out mental
health services [34, 35]. Enhancing the ability of medical
providers to communicate with patients about mental
health may also promote acceptability and reduce stigma
amongst patients who may be considering mental health
care. Both patients and parents reported the highest level

of comfort with rheumatologists and PCPs, likely due to
the high level of trust and familiarity that these clinicians
have with the rheumatological diagnosis [17]. Yet, many
of these medical providers may not be trained in mental
health assessment and intervention; this represents a gap
in care, for which efforts to provide primary care and
pediatric subspecialty physician training have been initiated by the American Board of Pediatrics Roadmap Project [36]. Additionally, as the majority of patients who
received treatment had accessed psychotherapy/
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counseling and psychotropic medication through PCP
and community services, our results highlight the importance of communication and partnership between
PCPs and rheumatologists to facilitate mental health
intervention for patients.
Patient and parent discomfort with social workers,
psychologists, and counselors/therapists might be due to
stigma surrounding receiving care from mental health
providers [37]. Stigma and label avoidance (unwillingness of those suffering from mental health conditions to
label them as such) are well-described barriers to those
with (or at risk for) mental health concerns in terms of
accessing treatment options such as counseling and/or
medication [38–41]. Additionally, specific to the
pediatric rheumatology context, a prior study found that
patients have limited or no access to mental health providers in North American pediatric rheumatology clinics,
and that these services are not typically presented as a
standard part of comprehensive rheumatological care
[12]. This is supported by our findings that of those who
used mental health resources for patients, only 22% of
patients and 17% of parents had accessed a social
worker. Although social workers may often be the most
accessible of these providers, patients and families may
be unaware of the role that they can play in facilitating
and providing mental health resources, as many social
workers believe that they are underutilized in this capacity [12]. Increased availability of social workers, psychologists and counselors in the pediatric rheumatology
setting, as well as integration and normalization of their
services as a part of standard rheumatological care may
increase both access and acceptance of mental health
treatment. For example, in the United Kingdom, the national Standards of Care for Pediatric Rheumatology include recommendation for clinical psychologists to be
core members of the multidisciplinary team, and the National Health Service of England requires formally
commissioned tertiary level pediatric rheumatology care
centers to have an embedded mental health professional
[42, 43]. These policies should be considered within the
North America and other regions, as they are likely to
increase familiarity of patients and parents with mental
health providers, and improve trust and utilization of
these mental health providers.
It is noteworthy that patients and parents were concordant in identifying the top two barriers to seeking
mental health services; these were concerns about a lack
of understanding by mental health providers about the
rheumatological disease, and about lack of adequate insurance coverage. While the latter finding is a known
general barrier from existing literature [37, 44], the concern about lack of understanding of disease is particularly relevant to providing effective intervention to youth
with rheumatological disease. These results suggest that
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even for those who can overcome insurance issues to access mental health services, there remains a need to address disease-specific issues within the course of mental
health treatment. This finding was echoed in the text responses regarding mental health resources, with several
respondents reflecting on the reduced helpfulness of
such resources due to a lack of disease-specific content.
These results indicate a clear need for affordable mental
health care options that are also disease-informed, to address the nuanced mental health challenges faced by patients with rheumatological conditions. Interventions to
address this need may include co-location of mental
health providers in pediatric rheumatology settings, educational initiatives to improve community mental health
provider knowledge of pediatric rheumatological conditions, and development of disease-specific peer support
and informational mental health resources. Encouragingly, mental health resources for pediatric chronic
disease patients and families are available from the
American Board of Pediatrics Roadmap Project, and
more are being developed, with acknowledgement that
they may benefit from tailoring to specific diseases and
individual patient needs.
Strengths & Limitations

The strengths of this study include the engagement of
patients and parents in the survey design, which was
critical to constructing survey items with language conducive to inquiring about the sensitive topic of mental
health. Engagement of a patient advocacy group such as
PARTNERS was also essential to optimizing the content,
design, advertisement and distribution of the survey to
reach a broad, national audience of patients and parents
through social media and other approaches. Administration of a survey in both English and Spanish also aimed
to increase representativeness.
This study also has limitations. First, since the survey
responses were self-reported and anonymous, there is
possibility of misclassification. We were not able to definitively confirm clinician diagnoses of rheumatological
disease; however, we think that our sample represents
the intended patient population, as reported medications
were similar to expected, with treatment use in JIA participants approximating that in the large CARRA JIA
Registry cohort [29]. We were also not able to confirm
reported mental health diagnoses, nor ask questions surrounding severity of reported mental health problems,
due to lack of a mechanism to identify and appropriately
refer participants posing potential harm to themselves or
others; however, the prevalence of reported cliniciandiagnosed mental health disorders is similar to other
studies of pediatric rheumatology patients. Second,
generalizability of our results to the larger pediatric
rheumatology patient population may be limited by
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several factors, including: the skewed demographic of
the sample (predominately white, educated, and highincome); limitation of the study to JIA, JDM, and cSLE
participants in order to leverage the PARTNERS member organizations which are focused on these diseases;
and potential enrichment of patients with more disease
burden (e.g. JDM and cSLE patients), comorbidities, and
mental health issues than the general pediatric rheumatology population. Furthermore, while our varied recruitment approach including clinic advertisements, email
listservs, and social media allowed us to reach a wider
audience, it made it impossible to calculate response rate
and gather information about those who did not
complete the survey, also limiting assessment of
generalizability of our results. Third, although we adjusted for patient characteristics in our comparisons between patient and parent responses, we could not
compare pairs of patient respondents and parents from
the same family due to the anonymous survey approach.
Fourth, while our stratification of patients into adolescents and young adults is generally relevant for availability of pediatric vs adult medical and mental health
services, we may not have captured differences in mental
health experiences for the subgroup transitioning to
adult care in their early 20s. Last, while we included the
perspectives from parents of patients as young as 8 years
old, the mental and behavioral health needs of these
younger children were not directly captured in this survey. Despite these limitations, our study provides important and much needed insight into the mental health
needs of youth with rheumatological disease, from their
own perspective and from their parents.

Conclusion
Youth with rheumatological disease in our study had
high rates of reported mental health problems, both clinician- and self-diagnosed. Barriers to mental health
treatment include disease-related and logistic factors,
and mental health intervention strategies are needed to
increase acceptance and accessibility of mental health
intervention for these patients. Areas of focus identified
by the experiences of patients and parents in this study
include: 1) increased mental health education of patients,
parents, medical and mental health providers; 2)
optimization of partnerships for improved integration of
medical and mental health care, and; 3) development
and provision of disease-tailored mental health services
and resources.
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